![Stephen Uden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Uden
Founder at
RALLYBIO CORPORATION
Net worth: 2 M $ as of 31/08/2026
Profile
Dr. Stephen Uden, MD, is a President, Chief Executive Officer & Director at Rallybio Corp.
and a President, Chief Executive Officer & Director at Rallybio LLC.
He is on the Board of Directors at Rallybio Corp.
and Rallybio LLC.
Dr. Uden was previously employed as a Senior Vice President-Research by Alexion Pharmaceuticals, Inc. and a Head-Research & Development by Neurogen Corp.
He received his undergraduate degree from the University of London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RALLYBIO CORPORATION 1.73% | 19/12/2025 | 91,920 ( 1.73% ) | 2 M $ | 31/08/2026 |
Stephen Uden active positions
| Companies | Position | Start |
|---|---|---|
| RALLYBIO CORPORATION | Founder | 01/01/2018 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Founder | 01/01/2018 |
Former positions of Stephen Uden
| Companies | Position | End |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2017 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Chief Tech/Sci/R&D Officer | 14/09/2007 |
Training of Stephen Uden
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
- Stock Market
- Insiders
- Stephen Uden
